James Dziura Selected Research

Obesity

3/2019	Elevated renalase levels in patients with acute coronary microvascular dysfunction - A possible biomarker for ischemia.
3/2015	Blunted suppression of acyl-ghrelin in response to fructose ingestion in obese adolescents: the role of insulin resistance.
7/2007	Degree of obesity and glucose allostasis are major effectors of glucose tolerance dynamics in obese youth.
6/2007	Interethnic differences in muscle, liver and abdominal fat partitioning in obese adolescents.
11/2006	Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat.
11/2006	Adiponectin in childhood and adolescent obesity and its association with inflammatory markers and components of the metabolic syndrome.
6/2004	Obesity and the metabolic syndrome in children and adolescents.
9/2003	Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James Dziura Research Topics

Disease

24	Insulin Resistance 01/2016 - 05/2003
11	Autism Spectrum Disorder 11/2023 - 03/2013
8	Obesity 03/2019 - 09/2003
7	Autistic Disorder (Autism) 11/2023 - 02/2016
7	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2016 - 06/2004
6	Inflammation (Inflammations) 01/2022 - 11/2006
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2020 - 12/2004
5	Pediatric Obesity 03/2015 - 05/2003
4	Tobacco Use Disorder (Nicotine Dependence) 02/2023 - 01/2018
4	Opioid-Related Disorders (Opiate Addiction) 01/2021 - 01/2020
3	COVID-19 01/2022 - 10/2020
3	Body Weight (Weight, Body) 11/2020 - 04/2005
3	Tics (Tic) 01/2018 - 05/2010
3	Fatty Liver 01/2013 - 11/2006
3	Hypoglycemia (Reactive Hypoglycemia) 12/2011 - 12/2004
3	Non-alcoholic Fatty Liver Disease 09/2011 - 11/2006
3	Weight Loss (Weight Reduction) 01/2010 - 04/2009
2	Fatigue 01/2022 - 12/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2020
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2021 - 02/2017
2	Overweight 11/2020 - 06/2004
2	Ischemia 03/2019 - 01/2016
2	Tic Disorders (Tic Disorder) 11/2013 - 05/2010
2	Neoplasms (Cancer) 09/2011 - 08/2009
2	Abdominal Obesity 01/2010 - 04/2008
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2009 - 08/2009
2	Type 2 Diabetes Mellitus (MODY) 12/2008 - 02/2005
2	Glucose Intolerance 03/2004 - 09/2003
1	Atrial Fibrillation 11/2023
1	Opiate Overdose 10/2023
1	Syncope (Fainting) 01/2023
1	Shock 01/2023
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2023
1	Ageusia (Hypogeusia) 01/2022
1	Anosmia 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	Stroke (Strokes) 01/2021
1	Hemorrhage 01/2021
1	Hemorrhagic Stroke 01/2021
1	Dementia (Dementias) 11/2020
1	Liver Diseases (Liver Disease) 11/2019
1	Chest Pain (Chest Pains) 03/2019
1	Tachycardia (Tachyarrhythmias) 01/2019
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 11/2018
1	Long QT Syndrome 11/2018
1	Congenital Heart Defects (Congenital Heart Defect) 11/2018
1	Hypertension (High Blood Pressure) 02/2017
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2017
1	Microvascular Angina (Cardiac Syndrome X) 01/2017

Drug/Important Bio-Agent (IBA)

26	Glucose (Dextrose)FDA LinkGeneric 11/2020 - 09/2003
12	Insulin (Novolin)FDA Link 11/2020 - 03/2004
11	Biomarkers (Surrogate Marker)IBA 11/2023 - 11/2006
9	LipidsIBA 09/2011 - 05/2003
5	Opioid Analgesics (Opioids)IBA 11/2023 - 01/2020
5	AdiponectinIBA 01/2013 - 05/2003
5	Triglycerides (Triacylglycerol)IBA 03/2010 - 05/2003
3	Buprenorphine (Subutex)FDA LinkGeneric 01/2021 - 01/2020
3	Nonesterified Fatty Acids (NEFA)IBA 04/2008 - 05/2003
2	renalaseIBA 01/2022 - 03/2019
2	Soaps (Soap)IBA 11/2021 - 06/2013
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2021 - 02/2017
2	C-PeptideIBA 11/2020 - 02/2008
2	CytokinesIBA 10/2020 - 11/2006
2	Risperidone (Risperdal Consta)FDA LinkGeneric 02/2016 - 01/2016
2	Alanine Transaminase (SGPT)IBA 01/2016 - 11/2006
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2012 - 02/2007
2	LDL CholesterolIBA 03/2011 - 06/2010
2	CholesterolIBA 03/2011 - 06/2010
2	HDL LipoproteinsIBA 06/2010 - 11/2006
2	HDL CholesterolIBA 06/2010 - 11/2006
2	AdipokinesIBA 02/2008 - 11/2006
2	C-Reactive ProteinIBA 11/2006 - 06/2004
1	Fentanyl (Sublimaze)FDA LinkGeneric 10/2023
1	camostatIBA 01/2022
1	Nucleic AcidsIBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2021
1	Serotonin and Noradrenaline Reuptake InhibitorsIBA 01/2021
1	Antidepressive Agents (Antidepressants)IBA 01/2021
1	Glucagon-Like Peptide-1 ReceptorIBA 11/2020
1	Exenatide (Byetta)FDA Link 11/2020
1	Neutralizing AntibodiesIBA 10/2020
1	Proteins (Proteins, Gene)FDA Link 03/2019
1	Fc Receptors (Fc Receptor)IBA 01/2019
1	teplizumabIBA 01/2019
1	Monoclonal AntibodiesIBA 01/2019
1	N 30IBA 11/2018
1	Antihypertensive Agents (Antihypertensives)IBA 02/2017
1	Ranolazine FDA Link 01/2017

Therapy/Procedure

10	Therapeutics 01/2022 - 12/2004
3	Nicotine Replacement Therapy 02/2023 - 01/2018
3	Injections 05/2010 - 12/2004
3	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2010 - 04/2009
2	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2023 - 01/2019
2	Glycemic Control 08/2006 - 12/2004
1	Polypharmacy 01/2023
1	Cardiopulmonary Resuscitation (CPR) 01/2022
1	Aftercare (After-Treatment) 01/2021
1	Length of Stay 01/2021
1	Home Nursing (Nursing, Home) 11/2020